Numinus Wellness’ Study On MDMA-Assisted Therapy For PTSD Gets Health Canada Nod

Numinus Wellness Inc. (TSXV: NUMI) announced today that it has secured approval from Health Canada to conduct its feasibility study on MDMA-assisted therapy to treat post-traumatic stress disorder. The health department recently issued a “letter of no objection”, allowing the proposed study to proceed.

The single-arm, open-label safety and feasibility study is sponsored by the Multidisciplinary Association for Psychedelic Studies through its subsidiary MAPS Public Benefit Corporation. 

In May 2021, MAPS reported the results from the Phase 3 clinical trial testing the efficacy and safety of MDMA-assisted therapy for PTSD. The results demonstrated that 88% of the participants that received the experimental sessions experienced clinically significant reduction in symptoms, with 67% no longer qualifying for a PTSD diagnosis compared to only 32% in the placebo group.

Selkirk Copper Mines — sponsored Sponsored · Selkirk Copper Mines

Following the federal regulatory approval, the company is gearing its study preparations to train staff, import medication, and obtain ethical approval related to COVID-19 protocols.

Beyond this study, the company is also undertaking further studies to assess the safety and psychoactive properties of the lab-produced extract from a Psilocybe mushroom product.

Numinus Wellness last traded at $1.14 on the TSX Venture.


Information for this briefing was found via Numinus Wellness. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Inside a Forgotten High-Grade Gold Mine in the Yukon | Blue Jay Gold [DD-on-the-GO Ep. 10]

WHICH MINING STOCKS CAN STILL RUN? | Mining Stock Mailbag [Nov. 9-13]

Silver’s Bull Market Isn’t Over | Peter Krauth

Recommended

Questcorp Begins 600 Metre Phase 2B Drill Program at La Union

Selkirk Copper Wraps 54,579 Metre Phase 2 Program at Minto, Hits 5.97% Copper Equivalent

Related News

Numinus Wellness Announces Expansion To Research Lab

Numinus Wellness (TSXV: NUMI) has expansion on its mind. The company this morning announced that...

Tuesday, March 9, 2021, 08:18:23 AM

Psychedelics: The Eight Capital Primer

Eight Capital recently produced a primer on the psychedelic sector saying that the companies are...

Monday, June 14, 2021, 03:38:00 PM

Numinus Wellness Successfully Extracts Psilocybin From Mushrooms

Numinus Wellness (TSXV: NUMI) this morning announced that it has completed the extraction of psilocybe...

Thursday, December 17, 2020, 08:26:09 AM

Numinus Wellness To Acquire MedBright AI In Bid To Add Artificial Intelligence To Portfolio

Numinus Wellness (TSX: NUMI) is set to get into the artificial intelligence business. The firm...

Thursday, June 20, 2024, 09:41:47 AM

Numinus Wellness Walks From Acquisition Of MedBright AI

Numinus Wellness (TSX: NUMI) has walked away from a plan to add artificial intelligence assets...

Monday, August 12, 2024, 10:08:35 AM